Exercise-induced lung cancer regression: Mechanistic findings from a mouse model

Cancer

Volumn 120, Issue 21, 2014, Pages 3302-3310

  Higgins, Kristin A ^a   Park, Dongkyoo ^a   Lee, Gee Young ^a   Curran, Walter J ^a   Deng, Xingming ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

adenocarcinoma; apoptosis; exercise; lung cancer; p53

Indexed keywords

CASPASE 3; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; PROTEIN MDM2; PROTEIN P53; PUMA PROTEIN;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER REGRESSION; CANCER TISSUE; CONTROLLED STUDY; EXERCISE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SITTING; TREADMILL EXERCISE; TUMOR GROWTH; UPREGULATION; WEIGHT CHANGE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; LUNG NEOPLASMS; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; EXERCISE; HUMANS; LUNG NEOPLASMS; MICE; MOTOR ACTIVITY; PHYSICAL CONDITIONING, ANIMAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84925026377     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28878     Document Type: Article

References (30)

1. Strath SJ, Kaminsky LA, Ainsworth BE, et al., Guide to the assessment of physical activity: Clinical and research applications: a scientific statement from the American Heart Association. Circulation. 2013; 128: 2259-2279.
2. Dhaliwal SS, Welborn TA, Howat PA,. Recreational physical activity as an independent predictor of multivariable cardiovascular disease risk [serial online]. PLoS One. 2013; 8: e83435.
3. Eheman C, Henley SJ, Ballard-Barbash R, et al., Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012; 118: 2338-2366.
4. Wen CP, Wai JP, Tsai MK, et al., Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011; 378: 1244-1253.
5. Irwin ML, Smith AW, McTiernan A, et al., Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the Health, Eating, Activity, and Lifestyle Study. J Clin Oncol. 2008; 26: 3958-3964.
6. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al., Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006; 24: 3535-3541.
7. Lin YY, Wu YC, Rau KM, Lin CC,. Effects of physical activity on the quality of life in Taiwanese lung cancer patients receiving active treatment or off treatment. Cancer Nurs. 2013; 36: E35-E41.
8. Takahashi T, Nau MM, Chiba I, et al., p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989; 246: 491-494.
9. Vogelstein B, Lane D, Levine AJ,. Surfing the p53 network. Nature. 2000; 408: 307-310.
10. Levine AJ,. p53, the cellular gatekeeper for growth and division. Cell. 1997; 88: 323-331.
11. Jin S, Levine AJ,. The p53 functional circuit. J Cell Sci. 2001; 114 (pt 23): 4139-4140.
12. Jenkins DE, Oei Y, Hornig YS, et al., Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis. 2003; 20: 733-744.
13. Laukkanen JA, Pukkala E, Rauramaa R, Makikallio TH, Toriola AT, Kurl S,. Cardiorespiratory fitness, lifestyle factors and cancer risk and mortality in Finnish men. Eur J Cancer. 2010; 46: 355-363.
14. Woods JA, Davis JM, Kohut ML, Ghaffar A, Mayer EP, Pate RR,. Effects of exercise on the immune response to cancer. Med Sci Sports Exerc. 1994; 26: 1109-1115.
15. Coussens LM, Werb Z,. Inflammation and cancer. Nature. 2002; 420: 860-867.
16. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD,. Physical activity and cancer prevention: pathways and targets for intervention. Sports Med. 2008; 38: 271-296.
17. Peel JB, Sui X, Adams SA, Hebert JR, Hardin JW, Blair SN,. A prospective study of cardiorespiratory fitness and breast cancer mortality. Med Sci Sports Exerc. 2009; 41: 742-748.
18. Peel JB, Sui X, Matthews CE, et al., Cardiorespiratory fitness and digestive cancer mortality: findings from the aerobics center longitudinal study. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1111-1117.
19. Lee IM, Sesso HD, Paffenbarger RS Jr,. Physical activity and risk of lung cancer. Int J Epidemiol. 1999; 28: 620-625.
20. Kerr JF, Wyllie AH, Currie AR,. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239-257.
21. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell. 2000; 100: 57-70.
22. Ashkenazi A, Pai RC, Fong S, et al., Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest. 1999; 104: 155-162.
23. Benimetskaya L, Miller P, Benimetsky S, et al., Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells. Mol Pharmacol. 2001; 60: 1296-1307.
24. Bartlett JD, Louhelainen J, Iqbal Z, et al., Reduced carbohydrate availability enhances exercise-induced p53 signaling in human skeletal muscle: implications for mitochondrial biogenesis. Am J Physiol Regul Integr Comp Physiol. 2013; 304: R450-R458.
25. Saleem A, Hood DA,. Acute exercise induces p53 translocation to the mitochondria and promotes a p53-Tfam-mtDNA complex in skeletal muscle. J Physiol. 2013; 59 (pt 14): 3625-3636.
26. Toledo F, Wahl GM,. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer. 2006; 6: 909-923.
27. Hornsby WE, Douglas PS, West MJ, et al., Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. Acta Oncol. 2014; 53: 65-74.
28. Fletcher O, Gibson L, Johnson N, et al., Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2-19.
29. Key TJ, Appleby PN, Reeves GK, Roddam AW,. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010; 11: 530-542.
30. Pollak M,. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008; 8: 915-928.